Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
BJU International|November 6, 2010
Low pretreatment total testosterone (< 3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancerEvanguelos Xylinas, Guillaume Ploussard, Xavier Durand, et al.
World Journal of Urology|November 26, 2010
Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumorsOlivier Alenda, Guillaume Ploussard, Pascal Mouracade, et al.
BJU International|August 27, 2004
Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancerDimitri Vordos, Bernard Paule, Francis Vacherot, et al.
BJU International|May 27, 2009
Predicting tumour location in radical prostatectomy specimens: same-patient comparisons of 21-sample versus sextant biopsyKevin De Laet, Alexandre de la Taille, Guillaume Ploussard, et al.
BJU International|May 12, 2010
The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core numberGuillaume Ploussard, Vidal Azancot, Nathalie Nicolaiew, et al.
BJU International|October 2, 2010
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patientsGuillaume Ploussard, Mohammad Ali Agamy, Olivier Alenda, et al.
European Urology|October 4, 2002
Urinary continence and erectile function: a prospective evaluation of functional results after radical laparoscopic prostatectomyLaurent Salomon, Aristotelis G Anastasiadis, Ran Katz, et al.
BJU International|November 8, 2008
Prognostic significance of microscopic bladder neck invasion in prostate cancerFrancisco Rodríguez-Covarrubias, Stéphane Larré, Mickael Dahan, et al.
Journal of Endourology|February 9, 2010
Intrafascial nerve-sparing radical prostatectomy with a laparoscopic robot-assisted extraperitoneal approach: early oncological and functional resultsEvanguelos Xylinas, Guillaume Ploussard, Laurent Salomon, et al.
Urologic Oncology|April 15, 2004
Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implicationsZivko Popov, Sixtina Gil-Diez-De-Medina, Vincent Ravery, et al.
Pageof 7